Review





Similar Products

94
Bioss mouse ifn beta elisa kit
Mouse Ifn Beta Elisa Kit, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse ifn beta elisa kit/product/Bioss
Average 94 stars, based on 1 article reviews
mouse ifn beta elisa kit - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

95
Multi Sciences (Lianke) Biotech Co Ltd elisa kits
Elisa Kits, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/elisa kits/product/Multi Sciences (Lianke) Biotech Co Ltd
Average 95 stars, based on 1 article reviews
elisa kits - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

95
Multi Sciences (Lianke) Biotech Co Ltd mouse ifn β ek2236
Mouse Ifn β Ek2236, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse ifn β ek2236/product/Multi Sciences (Lianke) Biotech Co Ltd
Average 95 stars, based on 1 article reviews
mouse ifn β ek2236 - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

94
MedChemExpress ifn β
(A) Heatmap of caspase 3/7 activity in mTGOs following irradiation <t>and</t> <t>IFN-β</t> treatment with escalating doses. Data represents the area under the curve after 2 days (n = 6 animals/condition). (B) Representative dot plots, and (C) FACS analysis of AnV-FITC/PI staining in 11-day-old mTGO-derived cells following IFN-β treatment from D5 (right) and vehicle treated (left, Ctr). Data shown are percentage (%) of positive cells. Each dot represents a different biological replicate. Lines connect the same biological replicate across conditions. (D) Representative images of mTGOs cultured from D0 with 2 or 20 ng/ml IFN-β (and controls) at D0, D4, D7 and D11. (E) Quantification of the organoid area of mTGOs cultured from D0 with 2 or 20 ng/ml IFN-β (and controls) measured at D0, D4, D7 and D11. (F) Quantification of OFE in sham-irradiated mTGOs and (G) 7 Gy-irradiated mTGOs after IFN-β treatment from D5 to D11. Data are shown as mean ± SEM. Group differences were evaluated with Student t- test. n=3-6 animals/condition. * p < 0.05, ** p < 0.01
Ifn β, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ifn β/product/MedChemExpress
Average 94 stars, based on 1 article reviews
ifn β - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

94
Sino Biological recombinant mouse ifn β
(A) Heatmap of caspase 3/7 activity in mTGOs following irradiation <t>and</t> <t>IFN-β</t> treatment with escalating doses. Data represents the area under the curve after 2 days (n = 6 animals/condition). (B) Representative dot plots, and (C) FACS analysis of AnV-FITC/PI staining in 11-day-old mTGO-derived cells following IFN-β treatment from D5 (right) and vehicle treated (left, Ctr). Data shown are percentage (%) of positive cells. Each dot represents a different biological replicate. Lines connect the same biological replicate across conditions. (D) Representative images of mTGOs cultured from D0 with 2 or 20 ng/ml IFN-β (and controls) at D0, D4, D7 and D11. (E) Quantification of the organoid area of mTGOs cultured from D0 with 2 or 20 ng/ml IFN-β (and controls) measured at D0, D4, D7 and D11. (F) Quantification of OFE in sham-irradiated mTGOs and (G) 7 Gy-irradiated mTGOs after IFN-β treatment from D5 to D11. Data are shown as mean ± SEM. Group differences were evaluated with Student t- test. n=3-6 animals/condition. * p < 0.05, ** p < 0.01
Recombinant Mouse Ifn β, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant mouse ifn β/product/Sino Biological
Average 94 stars, based on 1 article reviews
recombinant mouse ifn β - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

95
Multi Sciences (Lianke) Biotech Co Ltd elisa kit
(A) Heatmap of caspase 3/7 activity in mTGOs following irradiation <t>and</t> <t>IFN-β</t> treatment with escalating doses. Data represents the area under the curve after 2 days (n = 6 animals/condition). (B) Representative dot plots, and (C) FACS analysis of AnV-FITC/PI staining in 11-day-old mTGO-derived cells following IFN-β treatment from D5 (right) and vehicle treated (left, Ctr). Data shown are percentage (%) of positive cells. Each dot represents a different biological replicate. Lines connect the same biological replicate across conditions. (D) Representative images of mTGOs cultured from D0 with 2 or 20 ng/ml IFN-β (and controls) at D0, D4, D7 and D11. (E) Quantification of the organoid area of mTGOs cultured from D0 with 2 or 20 ng/ml IFN-β (and controls) measured at D0, D4, D7 and D11. (F) Quantification of OFE in sham-irradiated mTGOs and (G) 7 Gy-irradiated mTGOs after IFN-β treatment from D5 to D11. Data are shown as mean ± SEM. Group differences were evaluated with Student t- test. n=3-6 animals/condition. * p < 0.05, ** p < 0.01
Elisa Kit, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/elisa kit/product/Multi Sciences (Lianke) Biotech Co Ltd
Average 95 stars, based on 1 article reviews
elisa kit - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

95
Multi Sciences (Lianke) Biotech Co Ltd mouse ifn β elisa kit
(A) Heatmap of caspase 3/7 activity in mTGOs following irradiation <t>and</t> <t>IFN-β</t> treatment with escalating doses. Data represents the area under the curve after 2 days (n = 6 animals/condition). (B) Representative dot plots, and (C) FACS analysis of AnV-FITC/PI staining in 11-day-old mTGO-derived cells following IFN-β treatment from D5 (right) and vehicle treated (left, Ctr). Data shown are percentage (%) of positive cells. Each dot represents a different biological replicate. Lines connect the same biological replicate across conditions. (D) Representative images of mTGOs cultured from D0 with 2 or 20 ng/ml IFN-β (and controls) at D0, D4, D7 and D11. (E) Quantification of the organoid area of mTGOs cultured from D0 with 2 or 20 ng/ml IFN-β (and controls) measured at D0, D4, D7 and D11. (F) Quantification of OFE in sham-irradiated mTGOs and (G) 7 Gy-irradiated mTGOs after IFN-β treatment from D5 to D11. Data are shown as mean ± SEM. Group differences were evaluated with Student t- test. n=3-6 animals/condition. * p < 0.05, ** p < 0.01
Mouse Ifn β Elisa Kit, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse ifn β elisa kit/product/Multi Sciences (Lianke) Biotech Co Ltd
Average 95 stars, based on 1 article reviews
mouse ifn β elisa kit - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

95
InvivoGen mouse ifn β kit
a We confirmed the establishment of Batf2 -targeted deletion in mice (left panel). The mRNA levels of Batf2 in BMDM from indicated genotypes are shown (right panel, n = 3 biologically independent samples; data are presented as mean ± SEM; unpaired two-tailed t -test). b BMDM were transfected with 2.0 µg/mL ISD and 1.0 µg/mL poly(I:C) for 8 h, and total mRNA was extracted for bulk RNA sequencing. The transcriptomes were compared between wildtype and Batf2 −/− BMDM. Data represent biologically independent samples ( n = 2 per group). c GSEA shows the significantly altered pathways between wildtype and Batf2 −/− BMDM in response to STING stimulation. d – g BMDM from wildtype and Batf2 −/− mice were transfected with 3.0 µg/mL ISD ( d ), 1.0 µg/mL cGAMP ( e ), 1.0 µg/mL poly(I:C) ( f ) or 1.0 µg/mL 5′ppp-dsRNA ( g ) for 16 h. Total mRNA was extracted for qPCR. The fold changes of Ifnb1 , pan -Ifna and Cxcl10 are shown as indicated. Data represent biologically independent experiments ( n = 3). h , i Wild-type and Batf2 −/− BMDM were transfected with 3.0 µg/mL ISD ( h ) or 1.0 µg/mL cGAMP ( i ) for 24 h. The concentration <t>of</t> <t>Ifn-β</t> in the supernatant was measured by ELISA. Data represent biologically independent experiments ( n = 3). j Wild-type and Batf2 −/− BMDM were incubated with 10.0 µg/mL diABZI for 8 h. Ifn-β in the supernatant was measured by ELISA. Data represent biologically independent experiments ( n = 3). k , l Wild-type and Batf2 −/− BMDM were transfected with 1.0 µg/mL poly(I:C) ( k ) or 1.0 µg/mL 5′ppp-dsRNA ( l ) for 24 h. Ifn-β in the supernatant was quantified by ELISA. Data represent biologically independent experiments ( n = 3). m , n Wild-type and Batf2 −/− BMDM were transfected with 3.0 µg/mL ISD ( m ) or 1.0 µg/mL cGAMP ( n ). Cell lysates were collected at the indicated time points for immunoblot analysis. The experiment was performed in two biologically independent experiments. Comparisons in ( d – l ) were made using two-way ANOVA followed by multi-comparison tests and data are presented as mean ± SEM. Source data are provided as a Source Data file.
Mouse Ifn β Kit, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse ifn β kit/product/InvivoGen
Average 95 stars, based on 1 article reviews
mouse ifn β kit - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

Image Search Results


(A) Heatmap of caspase 3/7 activity in mTGOs following irradiation and IFN-β treatment with escalating doses. Data represents the area under the curve after 2 days (n = 6 animals/condition). (B) Representative dot plots, and (C) FACS analysis of AnV-FITC/PI staining in 11-day-old mTGO-derived cells following IFN-β treatment from D5 (right) and vehicle treated (left, Ctr). Data shown are percentage (%) of positive cells. Each dot represents a different biological replicate. Lines connect the same biological replicate across conditions. (D) Representative images of mTGOs cultured from D0 with 2 or 20 ng/ml IFN-β (and controls) at D0, D4, D7 and D11. (E) Quantification of the organoid area of mTGOs cultured from D0 with 2 or 20 ng/ml IFN-β (and controls) measured at D0, D4, D7 and D11. (F) Quantification of OFE in sham-irradiated mTGOs and (G) 7 Gy-irradiated mTGOs after IFN-β treatment from D5 to D11. Data are shown as mean ± SEM. Group differences were evaluated with Student t- test. n=3-6 animals/condition. * p < 0.05, ** p < 0.01

Journal: bioRxiv

Article Title: Radiation-induced interferon-I response impairs thyroid organoid function

doi: 10.64898/2026.01.14.699489

Figure Lengend Snippet: (A) Heatmap of caspase 3/7 activity in mTGOs following irradiation and IFN-β treatment with escalating doses. Data represents the area under the curve after 2 days (n = 6 animals/condition). (B) Representative dot plots, and (C) FACS analysis of AnV-FITC/PI staining in 11-day-old mTGO-derived cells following IFN-β treatment from D5 (right) and vehicle treated (left, Ctr). Data shown are percentage (%) of positive cells. Each dot represents a different biological replicate. Lines connect the same biological replicate across conditions. (D) Representative images of mTGOs cultured from D0 with 2 or 20 ng/ml IFN-β (and controls) at D0, D4, D7 and D11. (E) Quantification of the organoid area of mTGOs cultured from D0 with 2 or 20 ng/ml IFN-β (and controls) measured at D0, D4, D7 and D11. (F) Quantification of OFE in sham-irradiated mTGOs and (G) 7 Gy-irradiated mTGOs after IFN-β treatment from D5 to D11. Data are shown as mean ± SEM. Group differences were evaluated with Student t- test. n=3-6 animals/condition. * p < 0.05, ** p < 0.01

Article Snippet: IFN-β (MedChemExpress, #HY-P73130) was added to the media of gamma-irradiated and non-irradiated organoids at day 7 at a final concentration of 2 ng/mL and at the time of self-renewal.

Techniques: Activity Assay, Irradiation, Staining, Derivative Assay, Cell Culture

a We confirmed the establishment of Batf2 -targeted deletion in mice (left panel). The mRNA levels of Batf2 in BMDM from indicated genotypes are shown (right panel, n = 3 biologically independent samples; data are presented as mean ± SEM; unpaired two-tailed t -test). b BMDM were transfected with 2.0 µg/mL ISD and 1.0 µg/mL poly(I:C) for 8 h, and total mRNA was extracted for bulk RNA sequencing. The transcriptomes were compared between wildtype and Batf2 −/− BMDM. Data represent biologically independent samples ( n = 2 per group). c GSEA shows the significantly altered pathways between wildtype and Batf2 −/− BMDM in response to STING stimulation. d – g BMDM from wildtype and Batf2 −/− mice were transfected with 3.0 µg/mL ISD ( d ), 1.0 µg/mL cGAMP ( e ), 1.0 µg/mL poly(I:C) ( f ) or 1.0 µg/mL 5′ppp-dsRNA ( g ) for 16 h. Total mRNA was extracted for qPCR. The fold changes of Ifnb1 , pan -Ifna and Cxcl10 are shown as indicated. Data represent biologically independent experiments ( n = 3). h , i Wild-type and Batf2 −/− BMDM were transfected with 3.0 µg/mL ISD ( h ) or 1.0 µg/mL cGAMP ( i ) for 24 h. The concentration of Ifn-β in the supernatant was measured by ELISA. Data represent biologically independent experiments ( n = 3). j Wild-type and Batf2 −/− BMDM were incubated with 10.0 µg/mL diABZI for 8 h. Ifn-β in the supernatant was measured by ELISA. Data represent biologically independent experiments ( n = 3). k , l Wild-type and Batf2 −/− BMDM were transfected with 1.0 µg/mL poly(I:C) ( k ) or 1.0 µg/mL 5′ppp-dsRNA ( l ) for 24 h. Ifn-β in the supernatant was quantified by ELISA. Data represent biologically independent experiments ( n = 3). m , n Wild-type and Batf2 −/− BMDM were transfected with 3.0 µg/mL ISD ( m ) or 1.0 µg/mL cGAMP ( n ). Cell lysates were collected at the indicated time points for immunoblot analysis. The experiment was performed in two biologically independent experiments. Comparisons in ( d – l ) were made using two-way ANOVA followed by multi-comparison tests and data are presented as mean ± SEM. Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: BATF2 is a glutamine-responsive tumour suppressor required for type-I interferon-dependent anti-tumour immunity

doi: 10.1038/s41467-025-68027-2

Figure Lengend Snippet: a We confirmed the establishment of Batf2 -targeted deletion in mice (left panel). The mRNA levels of Batf2 in BMDM from indicated genotypes are shown (right panel, n = 3 biologically independent samples; data are presented as mean ± SEM; unpaired two-tailed t -test). b BMDM were transfected with 2.0 µg/mL ISD and 1.0 µg/mL poly(I:C) for 8 h, and total mRNA was extracted for bulk RNA sequencing. The transcriptomes were compared between wildtype and Batf2 −/− BMDM. Data represent biologically independent samples ( n = 2 per group). c GSEA shows the significantly altered pathways between wildtype and Batf2 −/− BMDM in response to STING stimulation. d – g BMDM from wildtype and Batf2 −/− mice were transfected with 3.0 µg/mL ISD ( d ), 1.0 µg/mL cGAMP ( e ), 1.0 µg/mL poly(I:C) ( f ) or 1.0 µg/mL 5′ppp-dsRNA ( g ) for 16 h. Total mRNA was extracted for qPCR. The fold changes of Ifnb1 , pan -Ifna and Cxcl10 are shown as indicated. Data represent biologically independent experiments ( n = 3). h , i Wild-type and Batf2 −/− BMDM were transfected with 3.0 µg/mL ISD ( h ) or 1.0 µg/mL cGAMP ( i ) for 24 h. The concentration of Ifn-β in the supernatant was measured by ELISA. Data represent biologically independent experiments ( n = 3). j Wild-type and Batf2 −/− BMDM were incubated with 10.0 µg/mL diABZI for 8 h. Ifn-β in the supernatant was measured by ELISA. Data represent biologically independent experiments ( n = 3). k , l Wild-type and Batf2 −/− BMDM were transfected with 1.0 µg/mL poly(I:C) ( k ) or 1.0 µg/mL 5′ppp-dsRNA ( l ) for 24 h. Ifn-β in the supernatant was quantified by ELISA. Data represent biologically independent experiments ( n = 3). m , n Wild-type and Batf2 −/− BMDM were transfected with 3.0 µg/mL ISD ( m ) or 1.0 µg/mL cGAMP ( n ). Cell lysates were collected at the indicated time points for immunoblot analysis. The experiment was performed in two biologically independent experiments. Comparisons in ( d – l ) were made using two-way ANOVA followed by multi-comparison tests and data are presented as mean ± SEM. Source data are provided as a Source Data file.

Article Snippet: The amount of Ifn-β and Tnf-α in the supernatant was measured by a mouse Ifn-β kit (luex-mifnbv2, Invivogen) and a Tnf-α ELISA kit (BMS6073, Invitrogen) according to the manufacturer’s instructions.

Techniques: Two Tailed Test, Transfection, RNA Sequencing, Concentration Assay, Enzyme-linked Immunosorbent Assay, Incubation, Western Blot, Comparison

a , b BMDM were cultured in media containing glutamine (0 g/L, 0.5 g/L or 5.0 g/L) for 24 h, followed by transfection with STING agonists. c , d BMDM were cultured in media containing 0.5 g/L ( c ) or 5 g/L ( d ) glutamine and transfected with cGAMP with or without of BPTES. Data are compared using one-way ANOVA. e , f Ifn-β in the supernatant from this figure ( a , b ) was quantified by ELISA. g BMDM were cultured in media containing varied levels of glutamine and then transfected with cGAMP. The protein lysates were subjected to immunoblotting. Data represent two biologically independent experiments. h BMDM were cultured in media containing varied levels of glutamine and transfected with ISD. ChIP analysis of the H3K27me3 mark in the promoter regions of Batf2 is compared using one-way ANOVA. i BMDM were cultured in media containing 0 g/L or 5.0 g/L glutamine for 24 h and transfected with ISD and OCR was compared. j Wild-type and Batf2 −/− BMDM were transfected with ISD and OCR was compared. k Female C57BL6/J mice on a control diet or glutamine-rich diet were implanted with NOOC1 cells subcutaneously. Mice were treated with PBS or c-di-AMP intratumoural injection ( n = 8). l , m The combination of CDA and JHU-083 was administered for 2 weeks ( n = 8). n UMAP rendering of scRNA-Seq of the TILs separated from 5k ( n = 8 mice per group), shown above is generated. o The relative cluster size change percent is shown. p The Batf2 expression level in each cluster is shown. q The expression levels of Batf2 were compared using a Wilcoxon test. r Bulk RNA-Seq was performed for 15 HNSCC specimens. A correlation analysis between BATF2-IFN-I target genes and glutamine metabolism is shown. Data in this figure ( a – h ) represent biologically independent experiments ( n = 3, mean ± SEM). Data in this figure ( i , j ) were compared by an unpaired two-tailed t -test and represent biologically independent samples ( n = 3, mean ± SEM). Comparisons in ( a , b and e , f ) were made using two-way ANOVA, followed by multi-comparison tests. The tumour growth in this figure ( k – m ) was compared using the generalized estimating equation (GEE) model.

Journal: Nature Communications

Article Title: BATF2 is a glutamine-responsive tumour suppressor required for type-I interferon-dependent anti-tumour immunity

doi: 10.1038/s41467-025-68027-2

Figure Lengend Snippet: a , b BMDM were cultured in media containing glutamine (0 g/L, 0.5 g/L or 5.0 g/L) for 24 h, followed by transfection with STING agonists. c , d BMDM were cultured in media containing 0.5 g/L ( c ) or 5 g/L ( d ) glutamine and transfected with cGAMP with or without of BPTES. Data are compared using one-way ANOVA. e , f Ifn-β in the supernatant from this figure ( a , b ) was quantified by ELISA. g BMDM were cultured in media containing varied levels of glutamine and then transfected with cGAMP. The protein lysates were subjected to immunoblotting. Data represent two biologically independent experiments. h BMDM were cultured in media containing varied levels of glutamine and transfected with ISD. ChIP analysis of the H3K27me3 mark in the promoter regions of Batf2 is compared using one-way ANOVA. i BMDM were cultured in media containing 0 g/L or 5.0 g/L glutamine for 24 h and transfected with ISD and OCR was compared. j Wild-type and Batf2 −/− BMDM were transfected with ISD and OCR was compared. k Female C57BL6/J mice on a control diet or glutamine-rich diet were implanted with NOOC1 cells subcutaneously. Mice were treated with PBS or c-di-AMP intratumoural injection ( n = 8). l , m The combination of CDA and JHU-083 was administered for 2 weeks ( n = 8). n UMAP rendering of scRNA-Seq of the TILs separated from 5k ( n = 8 mice per group), shown above is generated. o The relative cluster size change percent is shown. p The Batf2 expression level in each cluster is shown. q The expression levels of Batf2 were compared using a Wilcoxon test. r Bulk RNA-Seq was performed for 15 HNSCC specimens. A correlation analysis between BATF2-IFN-I target genes and glutamine metabolism is shown. Data in this figure ( a – h ) represent biologically independent experiments ( n = 3, mean ± SEM). Data in this figure ( i , j ) were compared by an unpaired two-tailed t -test and represent biologically independent samples ( n = 3, mean ± SEM). Comparisons in ( a , b and e , f ) were made using two-way ANOVA, followed by multi-comparison tests. The tumour growth in this figure ( k – m ) was compared using the generalized estimating equation (GEE) model.

Article Snippet: The amount of Ifn-β and Tnf-α in the supernatant was measured by a mouse Ifn-β kit (luex-mifnbv2, Invivogen) and a Tnf-α ELISA kit (BMS6073, Invitrogen) according to the manufacturer’s instructions.

Techniques: Cell Culture, Transfection, Enzyme-linked Immunosorbent Assay, Western Blot, Control, Injection, Generated, Expressing, RNA Sequencing, Two Tailed Test, Comparison

a , Stable EV control and Batf2-expressing MOC2-E6/E7 cells were transfected with Sting plasmid for 16 h. The mRNA was quantified by qPCR ( n = 3). b , c EV control and Batf2-expressing MOC2-E6/E7 cells were transfected with Sting plasmid for 24 h. b The amount of Ifn-β in the supernatant was measured by ELISA ( n = 3). c protein lysates were harvested for immunoblotting against the indicated markers. d EV or Batf2-expressing MOC2-E6/E7 cells were implanted subcutaneously and monitored for tumour burden in the wild-type female C57BL6/J mice ( n = 5 each group). The tumour growth was compared using the GEE model. e EV or Batf2-expressing MOC2-E6/E7 cells were implanted in Ifnar1 −/− mice ( n = 9 in EV group; n = 10 in Batf2-MOC2-E6/E7 group). Tumour growth was compared using the GEE model. f–i One million the EV or Batf2-expressing MOC2-E6/E7 cells were implanted subcutaneously in wild-type mice. On days 7, 14 and 21 after implantation, tumour tissues were processed into single-cell suspensions. Flow cytometry was used to evaluate the presence of p-Tbk1 + , p-Irf3 + , CD8⁺ and TCRγδ⁺ cells in the TME ( n = 4 in the Day 7 Batf2 and the Day 14 EV groups; n = 5 for other groups). j UMAP rendering of single-cell immune profiling of the TILs separated from the control ( n = 5) and Batf2-expressing ( n = 5) tumours grown in wild-type C57BL6/J mice from this figure ( d ) is shown. The significantly altered clusters between the two groups are labeled in red. k The relative percentage of TILs is shown. l T-cell clusters (13 + 16) were separated, and the volcano plot shows the differentially expressed genes between groups. m A gene set enrichment analysis was performed to identify the most significantly altered pathways in T-cells from this figure ( d ). Comparisons in ( a , b ) were made using two-way ANOVA followed by multi-comparison tests. Comparisons in ( f – i ) were made using an unpaired two-way t -test. Data in ( a , b and d – i ) are presented as mean ± SEM. Source data are provided.

Journal: Nature Communications

Article Title: BATF2 is a glutamine-responsive tumour suppressor required for type-I interferon-dependent anti-tumour immunity

doi: 10.1038/s41467-025-68027-2

Figure Lengend Snippet: a , Stable EV control and Batf2-expressing MOC2-E6/E7 cells were transfected with Sting plasmid for 16 h. The mRNA was quantified by qPCR ( n = 3). b , c EV control and Batf2-expressing MOC2-E6/E7 cells were transfected with Sting plasmid for 24 h. b The amount of Ifn-β in the supernatant was measured by ELISA ( n = 3). c protein lysates were harvested for immunoblotting against the indicated markers. d EV or Batf2-expressing MOC2-E6/E7 cells were implanted subcutaneously and monitored for tumour burden in the wild-type female C57BL6/J mice ( n = 5 each group). The tumour growth was compared using the GEE model. e EV or Batf2-expressing MOC2-E6/E7 cells were implanted in Ifnar1 −/− mice ( n = 9 in EV group; n = 10 in Batf2-MOC2-E6/E7 group). Tumour growth was compared using the GEE model. f–i One million the EV or Batf2-expressing MOC2-E6/E7 cells were implanted subcutaneously in wild-type mice. On days 7, 14 and 21 after implantation, tumour tissues were processed into single-cell suspensions. Flow cytometry was used to evaluate the presence of p-Tbk1 + , p-Irf3 + , CD8⁺ and TCRγδ⁺ cells in the TME ( n = 4 in the Day 7 Batf2 and the Day 14 EV groups; n = 5 for other groups). j UMAP rendering of single-cell immune profiling of the TILs separated from the control ( n = 5) and Batf2-expressing ( n = 5) tumours grown in wild-type C57BL6/J mice from this figure ( d ) is shown. The significantly altered clusters between the two groups are labeled in red. k The relative percentage of TILs is shown. l T-cell clusters (13 + 16) were separated, and the volcano plot shows the differentially expressed genes between groups. m A gene set enrichment analysis was performed to identify the most significantly altered pathways in T-cells from this figure ( d ). Comparisons in ( a , b ) were made using two-way ANOVA followed by multi-comparison tests. Comparisons in ( f – i ) were made using an unpaired two-way t -test. Data in ( a , b and d – i ) are presented as mean ± SEM. Source data are provided.

Article Snippet: The amount of Ifn-β and Tnf-α in the supernatant was measured by a mouse Ifn-β kit (luex-mifnbv2, Invivogen) and a Tnf-α ELISA kit (BMS6073, Invitrogen) according to the manufacturer’s instructions.

Techniques: Control, Expressing, Transfection, Plasmid Preparation, Enzyme-linked Immunosorbent Assay, Western Blot, Flow Cytometry, Labeling, Comparison